VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,816,765 | -72.8% | 727,615 | -28.9% | 0.00% | -75.0% |
| Q2 2023 | $25,090,503 | +2290.8% | 1,022,739 | +2167.7% | 0.01% | – |
| Q1 2023 | $1,049,477 | +91878.7% | 45,100 | 0.0% | 0.00% | – |
| Q4 2022 | $1,141 | -99.9% | 45,100 | 0.0% | 0.00% | – |
| Q3 2022 | $870,000 | -70.9% | 45,100 | -61.6% | 0.00% | -100.0% |
| Q2 2022 | $2,989,000 | -81.0% | 117,379 | -80.8% | 0.00% | -80.0% |
| Q1 2022 | $15,749,000 | +17.3% | 612,336 | +91.0% | 0.01% | +25.0% |
| Q4 2021 | $13,421,000 | +499.2% | 320,551 | +522.6% | 0.00% | +300.0% |
| Q3 2021 | $2,240,000 | +25.7% | 51,482 | +36.6% | 0.00% | 0.0% |
| Q2 2021 | $1,782,000 | -27.7% | 37,689 | -21.6% | 0.00% | 0.0% |
| Q1 2021 | $2,465,000 | +833.7% | 48,070 | +387.0% | 0.00% | – |
| Q4 2020 | $264,000 | -19.8% | 9,870 | +2.9% | 0.00% | – |
| Q3 2020 | $329,000 | – | 9,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |